Furthermore, the strongly activated intron retention of Sestrin-1 gene, together with the absence of its processed and normally spliced transcript, could significantly contribute to the genotypic distinction of melanoma from BCC and SCC skin cancers, and thus could be successfully adopted in the clinical management of the disease. Here, SESN1 is linked to skin basal cell carcinoma.